DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Cholic acid
Cholic acid
|||||||||||||III US005202354A United States Patent (19) (11) Patent Number: 5,202,354 Matsuoka Et Al
OCALIVA™ (Obeticholic Acid) Oral
Ocaliva (Obeticholic Acid)
Biliary Bile Acid Composition of the Human Fetus in Early Gestation
Cholic Acid for Treating Inborn Errors of Primary Bile Acid Synthesis NHS England Unique Reference Number URN1623 / NICE ID004
G Protein-Coupled Receptors
Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
TRANSPARENCY COMMITTEE Opinion 19 February 2014
Kolbam, INN-Cholic Acid
Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1
Cholic Acid and Chenodeoxycholic Acid for Treating Inborn Errors of Bile Acid Synthesis (All Ages)
AHRQ Healthcare Horizon Scanning System – Status Update Horizon
Glycyrrhizin Alleviates Nonalcoholic Steatohepatitis Via Modulating Bile Acids and Meta-Inflammation S
Biliary Bile Acids of Bears, Pandas, and Related Carnivores
The Concise Guide to Pharmacology 2019/20: Transporters
OCALIVA, INN-Obeticholic Acid
Chenodeoxycholic Acid Plus Cholic Acid Gut: First Published As 10.1136/Gut.38.4.623 on 1 April 1996
Reseptregisteret 2014–2018 the Norwegian Prescription Database 2014–2018
Top View
Changes in Glutathione Content in Liver Diseases: an Update
Novel Modulation of Adenylyl Cyclase Type 2 Jason Michael Conley Purdue University
Obeticholic Acid: First Global Approval
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Suppl Table 2.Xlsx
Glycyrrhizin Alleviates Non-Alcoholic Steatohepatitis Via Modulating Bile Acids and Meta
Gastrointestinal Drug Advisory Committee (GIDAC) Meeting
Treatment with Milk Thistle Extract (Silybum Marianum
Download Product Insert (PDF)
TGR5 As New Target in Diabetes Care
Efficacy of Hepatoprotective Agents with Or Without Antiviral Drugs on Liver Function and Fibrosis in Patients with Hepatitis B: a Meta-Analysis
Functional Disorders in the Sphincter of Oddi and Possibly Reflux-Associated Diseases in the Hepato-Biliary-Cholecysto-Pancreat
The Role of Ursodeoxycholic Acid on Cholestatic Hepatic Fibrosis in Infant Rats
Downloaded from the Protein Data Bank (PDB ID: 6VSB)
Cholic Acid) Capsules, for Oral Use Drink/Food (2.3) Initial U.S
Characterization of Novel Fluorescent Bile Salt Derivatives for Studying Human Bile Salt and Organic Anion Transporters S
(12) Patent Application Publication (10) Pub. No.: US 2002/0004065 A1 Kanios (43) Pub
Drug-Induced Liver Lesions: Modern Approaches to Treatment N. B. Gubergrits1, N
Mesh Terms for 2002
Inflammatory Bowel Disease in Mexico
Bile Acids Regulate Hepatic Low Density Lipoprotein Receptor Activity in The
205750Orig1s000
205750Orig1s000
Bile Salts Summary – December 2019 Page 2 | Proprietary Information
Evolvement of EU Regulations on Innovative Medicines’ Was Accepted for Poster Presentation at the 77Th International Pharmaceutical Federation
Targeting Quorum Sensing
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
G Protein-Coupled Receptors
Shibata, 1962
(19) United States (12) Patent Application Publication (10) Pub
(12) United States Patent (10) Patent No.: US 7,026,360 B1 Fest0 (45) Date of Patent: Apr
OCALIVA Safely and Effectively
Eparations Bind the Active Substance of Chenodeoxycholic Acid in the Intestine and Thus Prevent Its Reabsorption and Efficacy
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
Orphan Drug Designations and Approvals List As of 03‐01‐2016 Governs April 1, 2016
(12) Patent Application Publication (10) Pub. No.: US 2011/0117194A1 Kim Et Al
Comparison Between Ursodeoxycholic Acid and Silymarin in Anticonvulsive Drugs Induced Hypertransaminasemia